Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock - $0.01 Par Value
-
Shares outstanding
-
46,382,189
-
Number of holders
-
239
-
Total 13F shares, excl. options
-
44,393,122
-
Shares change
-
+279,930
-
Total reported value, excl. options
-
$1,614,401,834
-
Value change
-
+$1,417,948
-
Number of buys
-
100
-
Number of sells
-
-100
-
Price
-
$36.37
Significant Holders of AVANOS MEDICAL, INC. - Common Stock - $0.01 Par Value (AVNS) as of Q2 2021
282 filings reported holding AVNS - AVANOS MEDICAL, INC. - Common Stock - $0.01 Par Value as of Q2 2021.
AVANOS MEDICAL, INC. - Common Stock - $0.01 Par Value (AVNS) has 239 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 44,393,122 shares
of 46,382,189 outstanding shares and own 95.71% of the company stock.
Largest 10 shareholders include BlackRock Inc. (7,372,494 shares), VANGUARD GROUP INC (5,096,248 shares), WELLINGTON MANAGEMENT GROUP LLP (3,706,467 shares), Champlain Investment Partners, LLC (2,607,033 shares), PRICE T ROWE ASSOCIATES INC /MD/ (2,475,276 shares), Paradice Investment Management LLC (2,441,913 shares), DIMENSIONAL FUND ADVISORS LP (2,381,093 shares), RGM Capital, LLC (2,157,612 shares), STATE STREET CORP (1,794,439 shares), and MACQUARIE GROUP LTD (1,648,604 shares).
This table shows the top 239 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.